Diligent Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Sell |
47,407
-1,548
| -3% | -$40.5K | 0.25% | 111 |
|
|
2026
Q1 | $1.37M | Sell |
48,955
-756
| -2% | -$20.1K | 0.34% | 85 |
|
|
2025
Q4 | $1.24M | Sell |
49,711
-2,003
| -4% | -$50.5K | 0.3% | 93 |
|
|
2025
Q3 | $1.32M | Sell |
51,714
-1,186
| -2% | -$29.3K | 0.33% | 84 |
|
|
2025
Q2 | $1.28M | Sell |
52,900
-295
| -0.6% | -$6.88K | 0.3% | 94 |
|
|
2025
Q1 | $1.35M | Sell |
53,195
-3,088
| -5% | -$80.8K | 0.33% | 83 |
|
|
2024
Q4 | $1.49M | Buy |
56,283
+5
| +0% | +$136 | 0.34% | 76 |
|
|
2024
Q3 | $1.63M | Sell |
56,278
-772
| -1% | -$22.5K | 0.38% | 71 |
|
|
2024
Q2 | $1.6M | Sell |
57,050
-2,373
| -4% | -$65.3K | 0.4% | 66 |
|
|
2024
Q1 | $1.65M | Buy |
59,423
+706
| +1% | +$19.6K | 0.41% | 61 |
|
|
2023
Q4 | $1.69M | Buy |
58,717
+7,250
| +14% | +$219K | 0.46% | 50 |
|
|
2023
Q3 | $1.71M | Sell |
51,467
-6,099
| -11% | -$216K | 0.52% | 43 |
|
|
2023
Q2 | $2.11M | Buy |
57,566
+775
| +1% | +$30.2K | 0.62% | 30 |
|
|
2023
Q1 | $2.32M | Buy |
56,791
+292
| +0.5% | +$12.6K | 0.72% | 27 |
|
|
2022
Q4 | $2.89M | Buy |
56,499
+1,212
| +2% | +$58.1K | 0.95% | 17 |
|
|
2022
Q3 | $2.42M | Sell |
55,287
-98
| -0.2% | -$4.76K | 0.86% | 21 |
|
|
2022
Q2 | $2.9M | Buy |
55,385
+2
| +0% | +$102 | 0.99% | 18 |
|
|
2022
Q1 | $2.87M | Sell |
55,383
-3,221
| -5% | -$167K | 0.83% | 22 |
|
|
2021
Q4 | $3.46M | Sell |
58,604
-1,096
| -2% | -$54.3K | 0.97% | 20 |
|
|
2021
Q3 | $2.34M | Hold |
59,700
| – | – | 0.8% | 25 |
|
|
2021
Q2 | $2.34M | Sell |
59,700
-1,188
| -2% | -$46.2K | 0.79% | 25 |
|
|
2021
Q1 | $2.21M | Sell |
60,888
-275
| -0.4% | -$9.76K | 0.8% | 27 |
|
|
2020
Q4 | $2.25M | Sell |
61,163
-2,396
| -4% | -$87.9K | 0.9% | 26 |
|
|
2020
Q3 | $2.21M | Sell |
63,559
-362
| -0.6% | -$12.7K | 1.01% | 25 |
|
|
2020
Q2 | $1.98M | Sell |
63,921
-416
| -0.6% | -$14.1K | 0.97% | 25 |
|
|
2020
Q1 | $1.99M | Sell |
64,337
-390
| -0.6% | -$13.3K | 1.19% | 21 |
|
|
2019
Q4 | $2.41M | Sell |
64,727
-1,977
| -3% | -$70.4K | 1.09% | 21 |
|
|
2019
Q3 | $2.27M | Buy |
66,704
+569
| +0.9% | +$20.7K | 1.11% | 20 |
|
|
2019
Q2 | $2.72M | Sell |
66,135
-1,645
| -2% | -$65.3K | 1.35% | 15 |
|
|
2019
Q1 | $2.73M | Sell |
67,780
-485
| -0.7% | -$19.4K | 1.56% | 10 |
|
|
2018
Q4 | $2.83M | Sell |
68,265
-2,286
| -3% | -$94.9K | 1.85% | 9 |
|
|
2018
Q3 | $2.95M | Sell |
70,551
-2,134
| -3% | -$82.2K | 1.62% | 10 |
|
|
2018
Q2 | $2.5M | Sell |
72,685
-1,107
| -2% | -$37.8K | 1.52% | 12 |
|
|
2018
Q1 | $2.48M | Sell |
73,792
-474
| -0.6% | -$16.3K | 1.5% | 12 |
|
|
2017
Q4 | $2.55M | Sell |
74,266
-366
| -0.5% | -$12.5K | 1.63% | 9 |
|
|
2017
Q3 | $2.53M | Sell |
74,632
-3,634
| -5% | -$117K | 1.85% | 10 |
|
|
2017
Q2 | $2.49M | Sell |
78,266
-518
| -0.7% | -$16.3K | 1.77% | 12 |
|
|
2017
Q1 | $2.56M | Buy |
78,784
+3,127
| +4% | +$98.6K | 1.96% | 10 |
|
|
2016
Q4 | $2.33M | Buy |
75,657
+219
| +0.3% | +$6.69K | 1.85% | 10 |
|
|
2016
Q3 | $2.43M | Sell |
75,438
-416
| -0.5% | -$13.9K | 1.97% | 9 |
|
|
2016
Q2 | $2.53M | Buy |
75,854
+1,991
| +3% | +$63.5K | 2.41% | 8 |
|
|
2016
Q1 | $2.08M | Buy |
73,863
+12,068
| +20% | +$345K | 2.27% | 7 |
|
|
2015
Q4 | $1.89M | Sell |
61,795
-864
| -1% | -$27.2K | 2.14% | 7 |
|
|
2015
Q3 | $2.02M | Sell |
62,659
-106
| -0.2% | -$3.4K | 2.17% | 8 |
|
|
2015
Q2 | $2.07M | Hold |
62,765
| – | – | 2.17% | 6 |
|
|
2015
Q1 | $2.03M | Sell |
62,765
-316
| -0.5% | -$10K | 2.08% | 6 |
|
|
2014
Q4 | $1.99M | Buy |
+63,081
| New | +$1.81M | 2.03% | 6 |
|
Other funds holding PFE
Diligent Investors's PFE Position: Q2 2026 in Review
Diligent Investors reduced its Pfizer (PFE) stake by 3.2% in Q2 2026, selling an estimated $40.5K and leaving 47,407 shares worth $1.14M. The position accounts for 0.25% of the portfolio, ranked #111.
Diligent Investors first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $3.46M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Diligent Investors held 47,407 shares of Pfizer worth $1.14M as of Q2 2026.
- Diligent Investors sold 1,548 Pfizer shares in Q2 2026, an estimated $40.5K.
- Pfizer made up 0.25% of Diligent Investors's portfolio in Q2 2026, its #111 holding.
- Diligent Investors first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Diligent Investors's Pfizer position peaked at $3.46M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Diligent Investors's 13F filing for Q2 2026, filed 24 Jul 2026.